Divi's Laboratories Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: DIVISLAB BSE: 532488

₹9291.50

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #2 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited (this stock)	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹246,575 Cr

EV / EBITDA

56.5x

EV / Sales

22.41x

Market cap / Sales

22.41x

Earnings yield

1.19%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 3,037 Cr, up 22.7% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 891 Cr, up 60.0% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	2,974	1,165	891	₹33.5500
March 31, 2026	2,793	971	756	₹28.4400
Dec. 31, 2025	2,578	798	598	₹22.5600
Sept. 30, 2025	2,660	920	696	₹26.2400
June 30, 2025	2,357	747	557	₹20.9500
March 31, 2025	2,536	861	667	₹25.1200
Dec. 31, 2024	2,297	730	594	₹22.3900
Sept. 30, 2024	2,302	735	518	₹19.5100
June 30, 2024	2,063	603	430	₹16.1800
March 31, 2024	2,259	700	531	₹19.9900
Dec. 31, 2023	1,808	490	358	₹13.5000
Sept. 30, 2023	1,868	464	342	₹12.8900
June 30, 2023	1,730	478	345	₹12.9900

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	3,037	2,947	2,665	2,806	2,476	2,623	2,379	2,407	2,142	2,338	1,902	1,953	1,810
Operating revenue	2,974	2,793	2,578	2,660	2,357	2,536	2,297	2,302	2,063	2,259	1,808	1,868	1,730
Other income	63	154	87	146	119	87	82	105	79	79	94	85	80
Operating expenses	1,734	1,850	1,671	1,765	1,614	1,655	—	1,573	—	1,542	—	1,394	—
Operating profit	1,240	943	907	895	743	881	—	729	—	717	—	474	—
Operating profit margin	41.7%	33.8%	35.2%	33.6%	31.5%	34.7%	—	31.7%	—	31.7%	—	25.4%	—
Depreciation	132	120	116	113	112	107	99	98	97	94	95	94	93
Interest	6	6	6	8	3	0	—	1	—	2	—	1	—
Exceptional items, gain / (loss)	—	—	-74	—	—	—	—	—	—	—	—	—	—
Profit before tax	1,165	971	798	920	747	861	730	735	603	700	490	464	478
Tax	274	215	200	224	190	194	136	217	173	169	132	122	133
Net profit	891	756	598	696	557	667	594	518	430	531	358	342	345
EPS	33.55	28.44	22.56	26.24	20.95	25.12	22.39	19.51	16.18	19.99	13.50	12.89	12.99
Net profit (TTM)	2,941	2,607	2,518	2,514	2,336	2,209	2,073	1,837	1,661	1,576	1,364	1,317	1,462
EPS (TTM)	110.79	98.19	94.87	94.70	87.97	83.20	78.07	69.18	62.56	59.37	51.39	49.60	55.05

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	10,388	3,436	2,607
March 31, 2025	9,198	2,929	2,209
March 31, 2024	7,665	2,132	1,576
March 31, 2023	7,625	2,354	1,808

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	10.9%	9.7%	10,894^†	9,551^†	8,003^†	7,977^†	9,002^†	6,873^†	5,506^†	5,085^†	3,966^†	4,133^†
Operating revenue	10.9%	8.8%	10,388	9,198	7,665	7,625	8,880^†	6,799^†	5,311^†	4,880^†	3,837^†	4,057^†
Other income	—	—	506^†	353^†	338^†	352^†	122^†	74^†	196^†	205^†	128^†	76^†
Operating expenses	—	—	6,900^†	—	—	5,280^†	5,014^†	3,989^†	3,501^†	3,079^†	2,602^†	2,618^†
Operating profit	14.2%	4.4%	3,488^†	—	—	2,345^†	3,866^†	2,809^†	1,809^†	1,800^†	1,235^†	1,439^†
Operating profit margin	—	—	33.6%^†	—	—	30.8%^†	43.5%^†	41.3%^†	34.1%^†	36.9%^†	32.2%^†	35.5%^†
Depreciation	—	—	461^†	401^†	376^†	342^†	311^†	255^†	186^†	169^†	142^†	123^†
Interest	—	—	23^†	—	—	1^†	1^†	1^†	6^†	4^†	2^†	2^†
Exceptional items, gain / (loss)	—	—	-74^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	13.4%	5.5%	3,436	2,929	2,132	2,354	3,677^†	2,628^†	1,813^†	1,833^†	1,219^†	1,388^†
Tax	—	—	829^†	720^†	556^†	546^†	728^†	673^†	441^†	501^†	350^†	335^†
Net profit	13.0%	5.9%	2,607	2,209	1,576	1,808	2,949^†	1,955^†	1,373^†	1,333^†	870^†	1,053^†
EPS	13.0%	5.9%	98.19^†	83.20^†	59.37^†	68.11^†	111.06^†	73.63^†	51.71^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	33.6%^†	—	—	30.8%^†	43.5%^†	41.3%^†	34.1%^†	36.9%^†	32.2%^†	35.5%^†
EBIT margin	33.3%^†	—	—	30.9%^†	41.4%^†	38.7%^†	34.3%^†	37.6%^†	31.8%^†	34.3%^†
PBT margin	33.1%	31.8%	27.8%	30.9%	41.4%^†	38.7%^†	34.1%^†	37.6%^†	31.8%^†	34.2%^†
Net margin	25.1%	24.0%	20.6%	23.7%	33.2%^†	28.8%^†	25.8%^†	27.3%^†	22.7%^†	26.0%^†
Interest coverage	150.39x^†	—	—	4528.12x^†	5657.18x^†	3809.51x^†	300.22x^†	524.78x^†	731.16x^†	617.99x^†
Dividend payout	30.6%^†	36.1%^†	50.5%^†	44.0%^†	18.0%^†	0.0%^†	61.9%^†	—	—	—
Earnings retention	69.4%^†	63.9%^†	49.5%^†	56.0%^†	82.0%^†	100.0%^†	38.1%^†	—	—	—
Current ratio	5.47x	7.03x	—	—	—	—	—	—	—	—
Quick ratio	3.63x	4.89x	—	—	—	—	—	—	—	—
Debt to equity	0.00x	0.00x	—	—	—	—	—	—	—	—
Return on equity	15.6%	14.8%	—	—	—	—	—	—	—	—
Return on assets	13.1%	13.1%	—	—	—	—	—	—	—	—
Return on capital employed	19.3%^†	—	—	—	—	—	—	—	—	—
Asset turnover	0.52x	0.55x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	2,711	-2,218	-802	2,519	192
March 31, 2025	1,650	-803	-797	1,437	213
March 31, 2024	1,266	-268	-798	1,002	264
March 31, 2023	2,448	-2,707	-797	472	1,976
March 31, 2022	1,910	-2,195	-532	714	1,196

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	19,954	16,711	16,658	0	0	11,034	2,019	85	6,514	3,711
March 31, 2025	16,824	14,895	14,842	2	0	9,979	1,420	396	5,436	3,033
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.